Vizora日本語

Mochida PharmaceuticalMochida Pharmaceutical Co.,Ltd.4534東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

Mochida Pharmaceutical FY ending Mar 2021 results

Mochida Pharmaceutical brought in ¥103B in revenue.

Out of every ¥100 of sales, about ¥12 is left as operating profit.

Revenue changed +1.2% from the prior year, operating profit +36.3%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +1.2% · profit +36.3%, calculated from disclosed figures.

Operating leverage: 30.89× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2020 → FY ending Mar 2021

Revenue
+1.2%¥101.8B → ¥103B
Gross profit
+5.5%¥51.9B → ¥54.8B
Operating income
+36.3%¥8.81B → ¥12B
Net income attributable to owners
+86.8%¥4.6B → ¥8.59B
Operating cash flow
-1.6%¥9.35B → ¥9.2B
Free cash flow
-1.7%¥7.39B → ¥7.26B

Where the money goes

FY ending Mar 2020 → FY ending Mar 2021

Where ¥100 of sales goes

For every ¥100 Mochida Pharmaceutical sells, how much goes where, and how much is kept.

FY ending Mar 2021
Cost of sales
¥47
SG&A
¥41
Operating profit
¥12
Net profit kept
¥8

Annual margin trends

Gross margin53.2%
FY ending Mar 2020: 51.0%51.0%FY ending Mar 2021: 53.2%53.2%FY20FY21
Operating margin11.7%
FY ending Mar 2020: 8.7%8.7%FY ending Mar 2021: 11.7%11.7%FY20FY21
Net margin8.3%
FY ending Mar 2020: 4.5%4.5%FY ending Mar 2021: 8.3%8.3%FY20FY21

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (5)

  • EDINET (FSA Japan)

    有価証券報告書－第87期(2024/04/01－2025/03/31)

    ID S100W7OB2025-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第86期(2023/04/01－2024/03/31)

    ID S100TRAN2024-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第85期(2022/04/01－2023/03/31)

    ID S100R7OO2023-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第84期(令和3年4月1日－令和4年3月31日)

    ID S100OI5J2022-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第83期(令和2年4月1日－令和3年3月31日)

    ID S100LOG52021-06-29Open

Extracted from XBRL: 50 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image